BIO-key Demonstrates Award-Winning Biometric-Enhanced Cybersecurity Solutions at ScanSource Channel Connect Conference in Nashville Oct. 2-5
September 29 2022 - 6:58AM
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider
of Identity and Access Management (IAM) and Identity-Bound
Biometric (IBB) solutions, today announced it will demonstrate its
solutions and meet with partner prospects at 2022 ScanSource
Channel Connect (Booth 205) in Nashville, TN, October 2–5.
ScanSource Channel Connect combines for the first time the
ScanSource Partner Conference and Intelisys Channel Connect to
create an even greater opportunity for partners and suppliers to
gain knowledge, strengthen relationships, and create new
partnerships. BIO-key is the exclusive IAM provider for Intelisys,
the nation’s leading distributor of IT solutions and services and a
ScanSource company.
BIO-key will demonstrate its BIO-key
PortalGuard® IAM platform and BIO-key MobileAuthTM, its
one-of-a-kind, multi-factor authentication mobile app with new and
enhanced Identity-Bound Biometric capabilities. BIO-key solutions
make it easy for partners to address their customers’ most pressing
cybersecurity requirements and competitively differentiate their
business. BIO-key seeks to further expand its Channel Alliance
Partner (CAP) Program within the Intelisys partner community by
demonstrating the substantial revenue opportunities and customer
value its solutions provide.
“Despite the rise in cyberattacks, the market
for IAM is far from saturated – and expected to grow at a 14.5%
compound annual rate to more than $34 billion by 2028,” said Fred
Corsentino, Chief Revenue Officer of BIO-key, “creating a
significant revenue opportunity for BIO-key and our global partner
network. We look forward to informing partners and suppliers about
how to use BIO-key’s differentiated solutions to create profitable
and long-lasting customer relationships.”
Stop by booth 205 to learn about BIO-key’s
award-winning cybersecurity solutions and how partnering with
BIO-key can:
- Differentiate your cybersecurity
portfolio with Identity-Bound Biometrics;
- Build a new strong recurring
revenue stream for your business;
- Help your customers reduce cyber
risk & meet cyber insurance requirements;
- Provide an IAM solution that beats
the competition in both features and price; and
- Enhance your expertise and position
as a trusted cybersecurity advisor.
BIO-key’s award-winning PortalGuard IAM platform
has been implemented by 1,000+ customers worldwide to consolidate
security applications under a single, unified solution, reducing
overhead and improving productivity for users and the IT team.
PortalGuard is recognized for its flexible options for multi-factor
authentication (MFA), single sign-on, and self-service password
reset, with exclusive Identity-Bound Biometric authentication that
provides the highest levels of risk reduction, flexibility, and
cost efficiency. For enterprises dealing with passwordless
workflows, remote workforces, and customer IAM, BIO-key’s
MobileAuth MFA mobile app enables users to authenticate with
Identity-Bound Biometrics on any mobile device, eliminating the
risks and high costs associated with traditional authentication
methods.
For more information about 2022 ScanSource
Channel Connect, please visit the event website. To learn more
about BIO-key’s IAM solutions and CAP Program, please visit
BIO-key's website.
About BIO-key International,
Inc. (www.BIO-key.com) BIO-key has over two decades of
expertise in providing authentication technology for thousands of
organizations and millions of users and is revolutionizing
authentication with biometric-centric, multi-factor identity and
access management (IAM) solutions, including its PortalGuard IAM
solution, that provides convenient and secure access to devices,
information, applications, and high-value transactions. BIO-key's
patented software and hardware solutions, with industry-leading
biometric capabilities, enable large-scale on-premises and
cloud-based Identity-as-a-Service (IDaaS) solutions, as well as
customized enterprise solutions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than
statements of historical facts are "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995
(the "Act"). The words "estimate," "project," "intends," "expects,"
"anticipates," "believes," and similar expressions are intended to
identify forward-looking statements. Such forward-looking
statements are made based on management's beliefs, as well as
assumptions made by, and information currently available to,
management pursuant to the "safe harbor" provisions of the Act.
These statements are not guarantees of future performance or events
and are subject to risks and uncertainties that may cause actual
results to differ materially from those included within or implied
by such forward-looking statements. These risks and uncertainties
include, without limitation, our history of losses and limited
revenue; our ability to raise additional capital; our ability to
protect our intellectual property; changes in business conditions;
changes in our sales strategy and product development plans;
changes in the marketplace; continued services of our executive
management team; security breaches; competition in the biometric
technology industry; market acceptance of biometric products
generally and our products under development; the duration and
severity of the current coronavirus COVID-19 pandemic and its
effect on our business operations, sales cycles, personnel, and the
geographic markets in which we operate; delays in the development
of products and statements of assumption underlying any of the
foregoing as well as other factors set forth under the caption see
"Risk Factors" in our Annual Report on Form 10-K for the year ended
December 31, 2021 and other filings with the Securities and
Exchange Commission. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date made. Except as required by law, the Company undertakes
no obligation to disclose any revision to these forward-looking
statements whether as a result of new information, future events,
or otherwise. Additionally, there may be other factors of which the
Company is not currently aware that may affect matters discussed in
forward-looking statements and may also cause actual results to
differ materially from those discussed. In particular, the
consequences of the coronavirus outbreak to economic conditions and
the industry in general and the financial position and operating
results of our Company, in particular, have been material, are
changing rapidly, and cannot be predicted.
Engage with BIO-keyFacebook – Corporate:
https://www.facebook.com/BIOkeyInternational/ LinkedIn
– Corporate:
https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Media Contact Erin KnappMatter on behalf of
BIO-keyBIO-Key@matternow.com
Investor ContactsWilliam Jones, David Collins
Catalyst IR BKYI@catalyst-ir.com 212-924-9800
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Apr 2024 to May 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From May 2023 to May 2024